Notes to the Accounts (continued)

16. Programme-related investment in associates (continued)

b) onCore UK Cancer Research UK was one of two members of onCore UK, a charitable company limited by guarantee and incorporated in England and Wales. Control of the Board of Directors was shared equally between the three funders (Cancer Research UK, the Medical Research Council and the Department of Health). onCore UK was wound up on 20 February 2011.

Share of net assets

2011 £000

The Group’s one-third share of: Fixed assets

Current assets Creditors

Share of net assets Share of net result

2011 £000

The Group’s one-third share of: Voluntary income – grants Interest receivable Other income

Total incoming resources Charitable expenditure Governance costs

Deficit for the year

– 2 2

4

(140) (1)

(137)

2010 £000

– 2 9

11

(223) (1)

(213)

The financial information disclosed above is derived from unaudited draft accounts for onCore UK for its final period of operation to 20 February 2011. There are no related party disclosures that are required to be made for either the period to 20 February 2011 or for the year to 31 March 2010.

– – –

–

2010 £000

1 331

(15) 317

42 / Annual Report and Accounts / Notes to the Accounts